急性卒中大缺血核心的血管内取栓:随机对照试验的系统综述与Meta分析
该系统综述与Meta分析纳入6项随机对照试验共1870例因颈内动脉或大脑中动脉M1段闭塞所致急性卒中且为大缺血核心的患者,比较血管内取栓联合内科治疗与单纯内科治疗。取栓联合内科治疗与90天功能独立改善相关(RR 2.53,95%CI 1.95-3.29),并降低持续护理或死亡风险(RR 0.74,95%CI 0.66-0.84),早期症状性颅内出血比例无显著升高(RR 1.65,95%CI 1.00-2.70)。
要点
- 取栓联合内科治疗较单纯内科治疗与90天功能独立率更高相关(RR 2.53,95%CI 1.95-3.29)。
- 取栓联合内科治疗较单纯内科治疗与持续护理或死亡风险更低相关(RR 0.74,95%CI 0.66-0.84)。
- 两组早期症状性颅内出血比例无显著差异(RR 1.65,95%CI 1.00-2.70,p=0.05)。
核心结论
- 对于卒中前无残疾、因颈内动脉或大脑中动脉M1段闭塞所致急性卒中且为大缺血核心的患者,取栓联合内科治疗较单纯内科治疗可能与90天功能独立改善、残疾减轻及严重残疾或死亡比例降低相关。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Cochrane对照试验中心注册库和ClinicalTrials.gov,检索时间从2000年1月1日至2024年9月25日,无语言限制。
- 纳入比较取栓联合内科治疗与单纯内科治疗的急性卒中大缺血核心随机对照试验,共6项试验1870例患者(女性826例[44.2%])。
- 采用逆方差法的随机效应模型计算汇总估计值,使用GRADE评价证据质量。
主要发现
- 取栓联合内科治疗组较单纯内科治疗组90天功能独立(改良Rankin量表0-2分)比例更高(RR 2.53,95%CI 1.95-3.29;p<0.001;需治疗人数[NNT] 9,95%CI 6-15)。
- 取栓联合内科治疗组较单纯内科治疗组残疾减轻(改良Rankin量表序贯移位)更优(共同比值比1.63,95%CI 1.38-1.93;p<0.001;NNT 4,最小可能NNT 2,最大可能NNT 6)。
- 取栓联合内科治疗组较单纯内科治疗组持续护理或死亡(改良Rankin量表5-6分)风险更低(RR 0.74,95%CI 0.66-0.84;p<0.001;NNT 7,95%CI 6-11)。
- 取栓联合内科治疗组较单纯内科治疗组早期症状性颅内出血比例无显著差异(RR 1.65,95%CI 1.00-2.70;p=0.05)。
- 取栓联合内科治疗组与单纯内科治疗组死亡风险无显著差异(RR 0.86,95%CI 0.72-1.02;p=0.08)。
关键数值与推荐
- 主要结局为卒中后90天功能独立,定义为改良Rankin量表0-2分。
- 主要次要结局为残疾减轻,定义为改良Rankin量表序贯移位。
- 安全性结局包括需要持续护理或死亡(改良Rankin量表5-6分)、死亡和早期症状性颅内出血。
临床怎么用
- 原文结论指出,对于卒中前无残疾、因颈内动脉或大脑中动脉M1段闭塞所致急性卒中且为大缺血核心的患者,取栓联合内科治疗较单纯内科治疗可能与90天功能独立改善、残疾减轻及严重残疾或死亡比例降低相关。
局限性
- 主要局限性包括大缺血核心的影像学定义存在差异,以及分析中同时纳入较大中等核心和大缺血核心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular thrombectomy (EVT) is the standard treatment for acute ischemic stroke due to internal carotid artery (ICA) or middle cerebral artery (MCA) M1 occlusion with a small ischemic core. However, the effect of EVT on acute stroke with a large ischemic core remains unclear. This study aimed to evaluate the association of EVT plus medical care versus medical care alone with outcomes in patients with acute stroke and a large ischemic core due to ICA or MCA M1 occlusion. METHODS AND FINDINGS: PubMed, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched from January 1, 2000 to September 25, 2024. There were no language restrictions. Randomized controlled trials (RCTs) of patients with acute stroke and a large ischemic core that compared EVT plus medical care versus medical care alone were evaluated. We computed the random-effects estimate based on the inverse variance method. Risk ratio (RR) with 95% confidence interval (CI) was used to measure outcomes of EVT plus medical care versus medical care alone. The primary outcome was functional independence, defined as modified Rankin Scale (mRS) of 0-2 at 90 days post-stroke; and the lead secondary outcome was reduced disability, defined as ordinal shift of mRS. Safety outcomes were requiring constant care or death (mRS 5-6), death, and early symptomatic intracranial hemorrhage (sICH). Grading of Recommendations Assessment, Development and Evaluations (GRADE) was used to evaluate summaries of evidence for the outcomes. We included six RCTs comprising 1870 patients (826 females [44.2%]) with acute stroke and a larger moderate or large ischemic core due to ICA or MCA M1 occlusion. All patients were nondisabled before stroke. Pooled results showed that at 90 days post-stroke, EVT plus medical care, compared with medical care alone, was associated with greater functional independence (RR 2.53, 95% CI [1.95, 3.29]; p < 0.001; number needed to treat [NNT], 9, 95% CI [6,15]) and reduced disability (common odds ratio 1.63, 95% CI [1.38, 1.93]; p < 0.001; NNT, 4 [minimum possible NNT, 2; maximum possible NNT, 6]). EVT plus medical care, compared with medical care alone, was associated with a lower risk of requiring constant care or death (RR 0.74, 95% CI [0.66, 0.84]; p < 0.001; NNT, 7, 95% CI [6,11]). EVT plus medical care, compared with medical care alone, was associated with a nonsignificantly higher proportion of patients with early symptomatic intracranial hemorrhage (RR 1.65, 95% CI [1.00, 2.70]; p = 0.05). The rates of death were not significantly different between the EVT plus medical care and medical care alone groups (RR 0.86, 95% CI [0.72, 1.02]; p = 0.08). Main limitations include variability in imaging definitions of large core and inclusion of both larger moderate and large cores in the analysis. CONCLUSIONS: Among patients with acute stroke and a larger moderate or large ischemic core due to ICA or MCA M1 occlusion who were nondisabled before stroke, EVT plus medical care, compared with medical care alone, may be associated with improved functional independence, reduced disability, and reduced rates of severe disability or death at 90 days post-stroke. PROSPERO registration number: CRD42024514605.
引用
- Lin CH, Lee M, Ovbiagele B, et al. Endovascular thrombectomy in acute stroke with a large ischemic core: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2025. PMID: 40245084. doi:10.1371/journal.pmed.1004484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。